Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
Darmon
P
P
Curtillet
C
C
Boullu
S
S
Laugier
A
A
Dutour
A
A
Oliver
C
C
D001786:Blood Glucose / Q000378:metabolism*; D020405:Dermis / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D007332:Insulin Infusion Systems; D061268:Insulin Lispro; D007333:Insulin Resistance; D008875:Middle Aged; D009765:Obesity
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro